Nicole Grunenberg

Vaccine Efficacy of ALVAC-HIV and Bivalent Subtype C gp120–MF59 in Adults

Glenda Gray, Linda‐Gail Bekker, Fatima Laher et al. · New England Journal of Medicine · 2021 · 221 citations · Full text

Diversion of HIV-1 vaccine–induced immunity by gp41-microbiota cross-reactive antibodies

Wilton B. Williams, Hua-Xin Liao, M. Anthony Moody et al. · Science · 2015 · 202 citations

Safety, pharmacokinetics, and immunological activities of multiple intravenous or subcutaneous doses of an anti-HIV monoclonal antibody, VRC01, administered to HIV-uninfected adults: Results of a phase 1 randomized trial

Kenneth H. Mayer, Kelly E. Seaton, Yunda Huang et al. · PLoS Medicine · 2017 · 129 citations · Full text

Subtype C ALVAC-HIV and bivalent subtype C gp120/MF59 HIV-1 vaccine in low-risk, HIV-uninfected, South African adults: a phase 1/2 trial

Linda‐Gail Bekker, Zoe Moodie, Nicole Grunenberg et al. · The Lancet HIV · 2018 · 121 citations · Full text

Assessment of the Safety and Immunogenicity of 2 Novel Vaccine Platforms for HIV-1 Prevention

Lindsey R. Baden, Etienne Karita, Gaudensia Mutua et al. · Annals of Internal Medicine · 2016 · 84 citations · Full text